For example, SFRP1 is known to inhibit Epithelial to Mesenchymal Transition (EMT) [20] in NSCLC cell lines, and has previously been suggested as a potential biomarker for NSCLC [21]. This evidence concerns the gene SFRP1 and non-small cell lung carcinoma.